ATE213635T1 - Verfahren für die herstellung schmelz-granulierte sucralfatzubereitung - Google Patents

Verfahren für die herstellung schmelz-granulierte sucralfatzubereitung

Info

Publication number
ATE213635T1
ATE213635T1 AT95915338T AT95915338T ATE213635T1 AT E213635 T1 ATE213635 T1 AT E213635T1 AT 95915338 T AT95915338 T AT 95915338T AT 95915338 T AT95915338 T AT 95915338T AT E213635 T1 ATE213635 T1 AT E213635T1
Authority
AT
Austria
Prior art keywords
sucralfate
preparation
particles
melt
melting point
Prior art date
Application number
AT95915338T
Other languages
English (en)
Inventor
Katsuya Matsuda
Koichi Ozawa
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE213635T1 publication Critical patent/ATE213635T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT95915338T 1994-04-26 1995-04-18 Verfahren für die herstellung schmelz-granulierte sucralfatzubereitung ATE213635T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8885594 1994-04-26
JP18952094 1994-08-11
PCT/JP1995/000753 WO1995028938A1 (fr) 1994-04-26 1995-04-18 Preparation de sucralfate granulee et fondue et son procede de production

Publications (1)

Publication Number Publication Date
ATE213635T1 true ATE213635T1 (de) 2002-03-15

Family

ID=26430198

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95915338T ATE213635T1 (de) 1994-04-26 1995-04-18 Verfahren für die herstellung schmelz-granulierte sucralfatzubereitung

Country Status (12)

Country Link
US (1) US5718923A (de)
EP (2) EP0759300B1 (de)
KR (1) KR100264547B1 (de)
CN (1) CN1081921C (de)
AT (1) ATE213635T1 (de)
AU (1) AU693545B2 (de)
BR (1) BR9507533A (de)
CA (1) CA2188785C (de)
DE (1) DE69525620T2 (de)
ES (1) ES2173183T3 (de)
TW (1) TW350773B (de)
WO (1) WO1995028938A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2333425T5 (es) 1995-06-15 2012-08-28 Crucell Holland B.V. Sistemas de empaquetado para adenovirus recombinante humano destinados a terapia génica
WO2000024380A1 (en) * 1998-10-27 2000-05-04 Fuisz Technologies Ltd. Microparticles containing peg and/or peg glyceryl esters
FR2838647B1 (fr) * 2002-04-23 2006-02-17 Particules enrobees a liberation prolongee, leur procede de preparation et comprimes les contenant
US10716802B2 (en) 2013-03-15 2020-07-21 The Brigham And Women's Hospital, Inc. Compounds to modulate intestinal absorption of nutrients
KR101583452B1 (ko) * 2015-01-30 2016-01-11 주식회사 대웅제약 위장질환 치료용 의약 조성물
US10973846B2 (en) 2015-09-24 2021-04-13 The Brigham And Women's Hospital, Inc. Water-activated mucoadhesive compositions to reduce intestinal absorption of nutrients
KR101837104B1 (ko) * 2017-04-14 2018-03-09 한국프라임제약주식회사 수크랄페이트 합성 방법 및 이에 의한 수크랄페이트

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3714159C2 (de) * 1986-04-30 1996-09-19 Chugai Pharmaceutical Co Ltd Sucralfat-Zubereitung
IT1203901B (it) * 1987-04-15 1989-02-23 Lisapharma Spa Composizioni farmaceutiche sotto forma di sospensioni stabili di sucralfato esenti da agenti sospendenti
US4940465A (en) * 1987-05-27 1990-07-10 Felix Theeuwes Dispenser comprising displaceable matrix with solid state properties
US5196405A (en) * 1987-07-08 1993-03-23 Norman H. Oskman Compositions and methods of treating hemorrhoids and wounds
DK505488D0 (da) * 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme
DE4022944A1 (de) * 1990-07-19 1992-01-23 Merck Patent Gmbh Sucralfat-kautablette
EP0549794B1 (de) * 1990-08-31 2001-11-28 Chugai Seiyaku Kabushiki Kaisha Herstellung einer vorratslösung von in wasser suspendiertem sucralfat
JPH0539223A (ja) * 1990-11-26 1993-02-19 Chugai Pharmaceut Co Ltd スクラルフエート水性懸濁原液の工業的製造方法
US5417682A (en) * 1991-01-30 1995-05-23 Alza Corporation Device for administering active agent to biological environment
US5422108A (en) * 1991-09-19 1995-06-06 Smart Plants International Inc. Protection of plants against plant pathogens
JPH05238938A (ja) * 1992-02-28 1993-09-17 Teikoku Seiyaku Co Ltd スクラルファート懸濁液剤およびスクラルファートの投与方法

Also Published As

Publication number Publication date
ES2173183T3 (es) 2002-10-16
CN1147203A (zh) 1997-04-09
TW350773B (en) 1999-01-21
CA2188785A1 (en) 1995-11-02
EP1110540A1 (de) 2001-06-27
AU693545B2 (en) 1998-07-02
DE69525620D1 (de) 2002-04-04
BR9507533A (pt) 1997-09-02
EP0759300A4 (de) 1997-07-16
KR100264547B1 (ko) 2000-12-01
EP0759300B1 (de) 2002-02-27
DE69525620T2 (de) 2002-10-17
CN1081921C (zh) 2002-04-03
KR970702053A (ko) 1997-05-13
CA2188785C (en) 2004-05-11
WO1995028938A1 (fr) 1995-11-02
AU2224695A (en) 1995-11-16
MX9604994A (es) 1998-05-31
US5718923A (en) 1998-02-17
EP0759300A1 (de) 1997-02-26

Similar Documents

Publication Publication Date Title
AU3505095A (en) Process for making a hihg density detergent composition which includes selected recycle streams
SE9200858L (sv) Metod för framställning av pellets med fördröjd frisättning
MX9802181A (es) Procedimiento para hacer una composicion detergente de alta densidad controlando la aglomeracion dentro de un indice de dispersion.
AU3031597A (en) Dispersion process
MX9702101A (es) Procedimiento para hacer una composicion detergente de alta densidad en un solo mezclador/densificador con corriente de reciclado seleccionadas.
EP0362374A1 (de) Verfahren zur herstellung von kaugummi enthaltend mit wachs beschichtete bestandteile mit verzögerter verabreichung.
CA2062773A1 (en) Process for recovering paint overspray particles
WO1999031141A3 (de) Verfahren zur herstellung von regulären porösen perlcellulosen, die perlcellulosen und ihre verwendung
ATE213635T1 (de) Verfahren für die herstellung schmelz-granulierte sucralfatzubereitung
AU5153696A (en) New additive concentrates
GB1432383A (en) Method of producing a drying filter
AU5907499A (en) Continuous process for making a detergent composition
AU3485593A (en) Spheroidal particles useful for electrostatography
CA2143835A1 (en) Method for manufacturing spherical particles
PL351311A1 (en) Glass-type filler plastics and resins as well as method of obtaining same
JPS6446767A (en) Electrophotographic carrier
JPS5590531A (en) Amino resin molding material
JPS63141549A (ja) カルシウム茶
JPS5695246A (en) Manufacture of toner particle
DE3867586D1 (de) Verfahren zur herstellung von kakaopulver durch desagglomeration und kakaopulverhaltigem granulat durch anschliessende agglomeration.
RU94031141A (ru) Способ получения вяжущего

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties